“Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges With Personalized Immunotherapy Guided by PD-L1 Expression”. Journal of Analytical Oncology 14 (October 21, 2025): 49–61. Accessed November 1, 2025. https://www.neoplasiaresearch.com/index.php/jao/article/view/887.